Clinical Takeaway Cannabinoids, particularly products with measurable THC content, show modest but consistent evidence for reducing chronic pain compared to placebo in randomized controlled trials, though the overall certainty of evidence remains...
`Endocannabinoid System & PTSD: Cannabis Meta-Analysis`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments. Cannabis use does not appear to prevent or significantly undermine the effectiveness...
`Cannabinoids for Children: Clinical Evidence Reviewed`
Clinical Takeaway Current evidence on cannabinoids in pediatric patients spans 276 studies across multiple designs, capturing both plant-derived and pharmaceutical formulations used to treat medical conditions in children under 18. The research...
Endocannabinoid System: Cannabis for Chronic Pain Review
Clinical Takeaway Clinical trials show that cannabis-based products with higher THC content provide modest but measurable reductions in chronic pain compared to placebo. Evidence quality varies by product type, THC-to-CBD ratio, and...
endocannabinoid system clinical research: athlete mental health
Clinical Takeaway Retired professional athletes from high contact team sports show notable rates of depression, anxiety, and other mental health challenges after leaving their sport. Factors such as head trauma history, loss...
Endocannabinoid Research: Cannabinoids for Children Review
Clinical Takeaway Systematic review evidence supports cautious, condition-specific use of cannabinoids in pediatric patients, with the strongest data in epilepsy and certain pain or palliative conditions. Safety and efficacy profiles vary considerably...
Cannabis-Based Products for Chronic Pain: Clinical Evidence
Clinical Takeaway Clinical trials show that cannabis-based products containing THC provide modest reductions in chronic pain compared to placebo, though the overall quality of evidence remains low to moderate. The benefit appears...
Endocannabinoid System & PTSD: Cannabis in Dual Diagnosis
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments, and cannabis use does not appear to undermine treatment outcomes compared to...
medical cannabis evidence-based care: Phase 3 Trial Results
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated over a 12-week double-blind treatment period with extensions up to...